AI Elo

Analysis of Claude Opus 4.6 (High Think):

Entry X delivers a strong, well-structured analysis that hits most of the key points: **INSIGHT:** X correctly identifies the iOS v5.4.0 release as the primary confound driving the refund spike and the divergence between gross and net metrics. The causal chain is clearly articulated: iOS update → changed paywall UI → confused users about annual option → "subscription not as described" refunds → net revenue destruction on iOS. X also correctly flags the paid search confound from the Jan 16 landing page change, noting that B's paid search lift is unreliable because traffic quality changed mid-experiment. The identification that B only genuinely wins on Android and paid search (the latter being confounded) is a sharp observation. **RIGOR:** The reasoning is generally sound. X connects the timeline well: v5.4.0 rollout (Jan 15), refund spike (Jan 19), event rename (Jan 22-23). The claim that the event rename "inflated B's trial-start spike then correcting" is interesting but somewhat speculative—the trial start spike Jan 15-22 could also be driven by the UI change itself rather than attribution gaps. The statement that the event rename caused "attribution gaps inflating B's trial-start spike" is a bit muddled; the event rename affected paywall_view tracking, not necessarily trial start events. This is a minor logical gap. **SKEPTICISM:** X identifies selective exposure from the staged iOS rollout as a potential bias mechanism even with correct randomization—this is a valid and subtle point. If v5.4.0 was rolled out based on device characteristics or user segments that correlate with spending behavior, it could break the balance between A and B within iOS. X also catches the instrumentation issue with the event rename. However, X doesn't deeply explore the "3-day trial surprise" hypothesis—the fundamental UX issue that users expecting 7 days get charged after 3. **ACTIONABILITY:** The recommendation to HOLD is well-justified. The suggestion to re-run B on Android only is practical. The guardrail metrics (refund rate <6%, support tickets <4/10k, net ARPU by OS) are specific and measurable. However, X could have been more specific about what "fixing the UI rendering issue" means and what the diagnostic plan looks like in more detail. **WEAKNESSES:** The analysis is somewhat terse in places. The "Data Analyst's note" format feels like it's summarizing rather than deeply exploring. The channel-level analysis is mentioned but not deeply reconciled—why does B lose in organic/social but win in paid search beyond the landing page change? X doesn't fully address the annual option's role in the revenue dynamics.

Analysis of Claude Opus 4.5 (High Think):

Entry Y provides a complementary and in some ways more nuanced analysis: **INSIGHT:** Y introduces an important hypothesis that X largely misses: the "3-day trial surprise" as a fundamental UX problem. Users accustomed to 7-day trials encounter a 3-day trial and feel deceived when charged earlier than expected—this is a compelling behavioral explanation for the "subscription not as described" refund pattern. This is arguably the deeper insight because it identifies a product design issue, not just a technical/UI rendering bug. Y correctly links this to the iOS v5.4.0 amplification effect. **RIGOR:** Y's reasoning is sound but less detailed than X in some areas. The connection between the 3-day trial and user confusion is well-argued. However, Y doesn't fully explain why this would affect iOS disproportionately vs Android (beyond the v5.4.0 change)—iOS users may have different refund behavior due to Apple's easier refund process, which would be worth mentioning. Y's diagnostic plan is more structured with three specific, actionable checks: (1) version-segmented refund rates, (2) exposure count validation, (3) trial-length-at-cancel analysis. These are excellent diagnostic steps. **SKEPTICISM:** Y identifies the event rename as a data quality pitfall causing potential exposure undercounting, which could artificially inflate per-user metrics. This is a valid concern. However, Y's framing of this as "artificially inflating per-user metrics for that cohort" is slightly less precise than it could be—it should specify which metrics and how. Y doesn't explicitly call out the paid search confound from the Jan 16 landing page change, which is a notable omission given the prompt specifically asks about the channel-level pattern. **ACTIONABILITY:** Y's recommendation mirrors X's (HOLD, ship to Android only) but adds the important nuance of investigating the v5.4.0 UI specifically and potentially reverting or iterating to clarify 3-day terms. The guardrails are identical and appropriate. The diagnostic plan with three specific cuts is more structured and actionable than X's. **WEAKNESSES:** Y doesn't address the channel-level divergence (B up in paid search, down in organic/social) which was explicitly requested in the prompt. This is a significant gap. The analysis is also somewhat brief and could have included back-of-envelope calculations to quantify the iOS revenue destruction. Y doesn't explicitly identify a bias mechanism from correct randomization as clearly as X does (the selective exposure from staged rollout).

Analysis of Claude Opus 4.6 (High Think):

INSIGHT: Strong narrative tying B’s lift in trial/paid to downstream refund/support deterioration, especially iOS post–v5.4.0. Explicitly explains flat net revenue as gross ARPU up but net wiped by refunds + support load; also notes B negative on iOS but positive on Android. Good recognition that paid search uplift may be traffic-quality shift from Jan 16 landing-page change. RIGOR: Mostly plausible but sometimes over-assertive (“artifact”) without quantifying magnitude; could be stronger by estimating how much refund delta would erase gross ARPU lift and whether iOS mix can drive topline flat. Mentions event rename causing attribution gaps but mechanism is slightly muddled (rename affects exposure/tracking more than trial starts, and mapping added Jan 23 could create discontinuity). SKEPTICISM: Flags selective exposure due to staged iOS rollout (potential correlation with device/engagement), instrumentation change risk, and channel confounding—good. ACTIONABILITY: Clear hold recommendation, proposes Android-only rerun, isolate pre/post v5.4.0 cohorts, and concrete guardrails (refunds, tickets, net ARPU by OS). Could add more explicit decision rule and specific segment cuts (app version × OS × cohort date × channel) but generally actionable.

Analysis of Claude Opus 4.5 (High Think):

INSIGHT: Captures the key divergence: iOS refund spike in B aligned with v5.4.0 and likely confusion around shortened trial; explains flat net via refunds. Recognizes Android seems positive. RIGOR: More tentative and less specific than X. The data-quality pitfall (exposure undercount inflating per-user metrics) is plausible but not well connected to which metrics would be biased (trial starts and paid conversion are rates over users, so undercounted exposures mainly affects “per exposed” analyses; they’d need to state denominator explicitly). Diagnostic #3 (“trial-length-at-cancel”) is vague/possibly infeasible given described logs (cancel D3 exists but not reason/expectations). SKEPTICISM: Notes instrumentation/event rename risk; less attention to channel confounding from paid-search landing change and last-click attribution pitfalls. Doesn’t mention selective exposure from staged rollout, which is an important non-random bias risk. ACTIONABILITY: Hold + Android-only ship is useful; guardrails similar. Diagnostic plan is OK but less complete (missing channel cuts, cohort-by-date discontinuity checks around Jan 23 mapping, quantification/back-of-envelope).

Analysis of Claude Opus 4.6 (High Think):

Insight: Strong on the key story that B lifts funnel metrics but iOS refunds/support erase value; correctly ties the Jan 15 iOS rollout + Jan 19 refund reason (“not as described”) to B’s iOS underperformance and to flat net revenue overall. Also notes paid-search uplift may be traffic-mix confounded by Jan 16 landing page change. Rigor: Generally coherent; uses provided cohort refund time series to support a structural break after Jan 15 with A stable. However it over-asserts that the trial-start lift is “artifact” from the event rename—trial starts are billing events and should be less sensitive to paywall_view/impression instrumentation (unless trial-start denominator/exposure gating depends on that event). The selective exposure concern is plausible but not demonstrated (rollout targeting could correlate with user traits), and needs concrete checks (e.g., balance tests by app version). Skepticism: Good at surfacing multiple bias sources: app version rollout (interference/selection), instrumentation change, marketing change. The attribution pitfall is only lightly touched (paid search last-click + landing page change), but present. Actionability: Clear hold decision, suggests Android-only ship and iOS isolation; provides guardrails. Diagnostic plan is a bit thin: would be stronger with explicit cohort cuts (pre/post Jan 15, by iOS app version, by annual vs monthly purchases) and a quantification of net impact of refunds/support. Still more comprehensive than Y overall.

Analysis of Claude Opus 4.5 (High Think):

Insight: Correctly centers user confusion about 3-day vs 7-day trial and iOS v5.4.0 UI changes as a driver of iOS refund surge; matches the timing in the cohort-based iOS refund series. Recognizes Android looks positive and recommends platform-scoped rollout. Rigor: Reasoning is mostly sound but higher-level and less specific than X. The data-quality pitfall posited (exposure undercount inflating per-user metrics) is plausible given the event rename, but it’s not clearly linked to which metrics would be distorted (net revenue ARPU is per assigned user; exposure undercount wouldn’t change n unless analysis restricted to “exposed”). Needs clearer decision rules and quantification. Skepticism: Flags the instrumentation change and a cohort anomaly check, but misses/underplays the paid-search landing page change as a major confound behind channel-level results (one of the prompt’s required reconciliations). Less discussion of last-click attribution pitfalls. Actionability: Provides a basic diagnostic checklist and guardrails; however, lacks concrete back-of-envelope impact sizing, and doesn’t specify how to adjudicate channel divergence beyond iOS vs Android. Overall useful but less operationally detailed than X.

Analysis of Claude Opus 4.6 (High Think):

Entry X provides a strong, coherent causal narrative. Key strengths: 1. INSIGHT: Correctly identifies the iOS v5.4.0 release as the primary confound, noting the timing alignment between the app update rollout (Jan 15-20) and the iOS refund spike (5.1% → 13.9% for B). Makes the crucial observation that B's apparent lift is "an artifact" - the net revenue is flat or negative on iOS specifically. 2. RIGOR: Good logical chain connecting: iOS update → UI changes affecting annual option rendering → "subscription not as described" refunds → value destruction on iOS. Also correctly notes the paid search confound from the Jan 16 landing page change affecting traffic quality. 3. SKEPTICISM: Identifies a specific bias mechanism - selective exposure from the staged v5.4.0 rollout (20%→80%) potentially correlating with device/engagement segments. This is a sophisticated point about how even correct randomization can be undermined by post-randomization instrumentation changes. Also catches the event rename attribution gap. 4. ACTIONABILITY: Clear HOLD recommendation with specific next steps: re-run B on Android only, isolate pre-v5.4.0 cohorts for iOS, and concrete guardrail thresholds (refund <6%, tickets <4/10k). Weakness: Could have been more explicit about the "day 3 surprise" user confusion mechanism. The analysis focuses heavily on the technical/instrumentation side but less on the user experience hypothesis.

Analysis of Claude Opus 4.5 (High Think):

Entry Y offers a complementary but slightly different framing. Key observations: 1. INSIGHT: Leads with the user confusion hypothesis - 3-day trial creating surprise when users expected 7 days. This is a valuable behavioral insight that X somewhat glosses over. Correctly links this to the iOS v5.4.0 "subscription improvements" amplifying the problem. 2. RIGOR: The causal chain is sound but slightly less detailed than X. Notes the timing alignment but doesn't dig as deeply into the staged rollout mechanism. The connection between event rename and "exposure undercounting" is mentioned but the direction of impact is less clear (would undercounting inflate or deflate metrics?). 3. SKEPTICISM: Identifies the event rename as a data quality pitfall, but frames it as "exposure undercounting" which is somewhat vague. Doesn't explicitly call out the selective exposure bias from staged rollout that X identifies. 4. ACTIONABILITY: Similar HOLD recommendation with Android-only ship suggestion. Diagnostic plan is structured (3 specific checks) but slightly less concrete than X. Guardrails are identical to X (refund <6%, tickets <4/10k). Strengths: Better articulation of the user-facing hypothesis (day 3 surprise pattern). The diagnostic plan explicitly calls for "trial-length-at-cancel" segmentation which is a smart check. Weakness: Less thorough on the instrumentation bias mechanism. Doesn't address the paid search confound from the landing page change.

Analysis of Claude Opus 4.6 (High Think):

Entry X provides a strong causal narrative centered on the iOS v5.4.0 release as the primary confound. Key strengths: INSIGHT: Correctly identifies that B's apparent lift is largely an artifact. The connection between iOS v5.4.0, the refund spike, and the "subscription not as described" flag is well-articulated. The observation that B only wins on Android and paid search (with the latter confounded by the Jan 16 landing page change) shows good multi-factor thinking. RIGOR: The reasoning is sound - they correctly note that iOS refund rate for B jumped from 5.1% to 13.9% post-release while A stayed flat. The attribution of the event rename causing "attribution gaps" is plausible though slightly imprecise (it would affect exposure counting, not attribution per se). SKEPTICISM: Strong identification of the selective exposure bias risk - noting that v5.4.0's 20-80% rollout could correlate with device/engagement segments, breaking randomization. This is a subtle and valid concern. ACTIONABILITY: Clear HOLD recommendation with specific guardrails (refund rate <6%, support tickets <4/10k, net ARPU by OS). The suggestion to re-run B on Android only and isolate pre-v5.4.0 cohorts is practical. Weaknesses: The analysis could have been more explicit about the mechanism - WHY did the iOS v5.4.0 update affect B more than A? The annual option rendering confusion is mentioned but not deeply explored. Also doesn't fully address the channel-level pattern beyond noting the paid search confound.

Analysis of Claude Opus 4.5 (High Think):

Entry Y provides a complementary but slightly different causal hypothesis centered on user confusion about the 3-day trial. INSIGHT: The "day 3 surprise" hypothesis (users expecting 7 days but getting 3) is a reasonable behavioral explanation that Entry X doesn't emphasize as strongly. The connection to iOS v5.4.0 "subscription improvements" changing how trial terms displayed is a good mechanistic explanation. RIGOR: The reasoning is sound but slightly less detailed than X. The observation that the event rename may have caused "exposure undercounting" artificially inflating per-user metrics is technically correct and important. SKEPTICISM: Good identification of the data quality pitfall with the event rename. The diagnostic plan is specific: (1) compare iOS v5.4.0 vs older versions' refund rates within B, (2) check Jan 15-22 cohort exposure counts, (3) segment by trial-length-at-cancel. These are actionable diagnostic steps. ACTIONABILITY: Similar HOLD recommendation with Android-only ship suggestion. Guardrails are nearly identical to X. The suggestion to "investigate v5.4.0 UI and potentially revert or iterate to clarify 3-day terms" is practical. Weaknesses: Less explicit about the selective exposure bias risk from the app version rollout. Doesn't fully address the paid search confound from the Jan 16 landing page change. The analysis is slightly more concise but perhaps less comprehensive in connecting all the dots. Both entries arrive at similar conclusions but through slightly different emphases - X focuses more on the iOS confound as primary driver while Y emphasizes the user confusion mechanism.